Titre:
  • Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer.
Auteur:Dieli, F; Vermijlen, David; Fulfaro, Fabio; Caccamo, N; Meraviglia, S; Cicero, G; Roberts, Andrew; Buccheri, S; D'Asaro, M; Gebbia, Nicola; Salerno, Alfredo; Eberl, M; Hayday, A C
Informations sur la publication:Cancer research, 67, 15, page (7450-7457)
Statut de publication:Publié, 2007-08
Sujet CREF:Immunologie
MeSH keywords:Aged
Aged, 80 and over
Antineoplastic Agents -- therapeutic use
Bone Density Conservation Agents -- therapeutic use
Diphosphonates -- therapeutic use
Dose-Response Relationship, Drug
Drug Therapy, Combination
Feasibility Studies
Humans
Imidazoles -- therapeutic use
Immunotherapy -- methods
Interleukin-2 -- therapeutic use
Lymphocyte Activation -- drug effects
Male
Middle Aged
Neoplasms, Hormone-Dependent -- drug therapy
Prostatic Neoplasms -- drug therapy
Receptors, Antigen, T-Cell, gamma-delta
Remission Induction
Salvage Therapy
T-Lymphocytes -- cytology -- drug effects -- immunology
Treatment Outcome
Note générale:Journal Article
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:0008-5472
info:doi/10.1158/0008-5472.CAN-07-0199
info:pii/67/15/7450
info:scp/34547638252
info:pmid/17671215
info:ulb-repo/set/1#37174